Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BY 4.0Molecules

Salidroside Represses the Viability of Mouse Sertoli Cell Line (TM4 Cells) via Repression of Ldha-Dependent Glycolysis

  1. 1College of Animal & Veterinary Sciences, Southwest Minzu University, Chengdu 610041, China

Abstract

Salidroside is a bioactive compound extracted from the traditional Chinese medicinal plant Rhodiola rosea that exerts differential regulatory effects on cell viability depending on cell type and physiological state. Sertoli cells are important testicular somatic cells that play multiple roles in nourishing, protecting, and supporting spermatogenic cells. Currently, the regulatory effects and underlying mechanisms of salidroside on Sertoli cells remain unclear. This study investigated the effects of different concentrations of salidroside on the viability and regulatory mechanisms of TM4 cells (mouse Sertoli cell line). The results showed that within the range of 25–600 μM, cell viability decreased with increasing salidroside concentration. Treatment with 600 μM salidroside inhibited proliferation, promoted apoptosis, and suppressed the expression of key genes related to Sertoli cell function. Transcriptome sequencing revealed that several glycolysis-related genes, including Ldha, Pfkl, Eno3, and Eno1b, were significantly downregulated in salidroside-treated cells, accompanied by marked reductions in key glycolytic metabolites, including fructose-1,6-diphosphate (FDP), pyruvate, lactic acid, and ATP. Notably, overexpression of lactate dehydrogenase A (Ldha) rescued cell viability and proliferation, suppressed apoptosis, elevated both intracellular and extracellular lactate and ATP levels, and partially restored functional gene expression in 600 μM salidroside-treated cells. Overall, this study provides hitherto undocumented evidence of the regulatory effects and mechanisms of salidroside on TM4 cells, identifying the Ldha–glycolytic axis as an in vitro cellular target of high-dose salidroside in Sertoli cells, which may inform future in vivo reproductive safety profiling pending pharmacokinetic validation.

Related

  1. A Hox-dependent anchoring mechanism mediates transcriptional repression of autophagy-related genes at the nuclear periphery
    Solène Vanderperre, Leiore Ajuria, Marilyne Duffraisse +5
    Proceedings of the National Academy of Sciences of the United States of AmericaPeer-reviewedCC BY-NC-NDFull text1 citedMolecular biology & gene regulationHAL
  2. The m6A Reader IGF2BP2 Drives Depressive-like Behaviors Through m6A-Dependent Repression of Astrocytic GLUT1 and Glucose Metabolism
    Zijing Liu, Jiayu Li, Kexin Meng +3
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. Salidroside Regulates Energy Metabolism Reprogramming to Suppress Tumor Proliferation: Mechanisms and Therapeutic Implications
    Haolin Wang, Yuxin Du
    MetabolitesPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossrefEurope PMC
  4. Salidroside ameliorates glucocorticoid-induced osteoporosis by regulating the PI3K/Akt/mTOR pathway: a network pharmacology and in vivo
    Kun Ren, Ying Huai, Xin Dong +3
    Scientific ReportsPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  5. Salidroside inhibits glioma cell migration and proliferation through CYP2E1-neuroglobin-cytochrome c mediated redox axis
    Lakshmi Priya Panda, Kalpana Barhwal, Amit Kumar +5
    Frontiers in oncologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
BibTeX
@article{wang2026salidroside,
  title = {{Salidroside Represses the Viability of Mouse Sertoli Cell Line (TM4 Cells) via Repression of Ldha-Dependent Glycolysis}},
  author = {Xinran Wang and Ruixue Huang and Gan Yang and Yuxia He and Shi Yin},
  journal = {Molecules},
  year = {2026},
  month = oct,
  doi = {10.3390/molecules31193575},
  url = {https://www.mdpi.com/1420-3049/31/19/3575},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Salidroside Represses the Viability of Mouse Sertoli Cell Line (TM4 Cells) via Repression of Ldha-Dependent Glycolysis
AU  - Xinran Wang
AU  - Ruixue Huang
AU  - Gan Yang
AU  - Yuxia He
AU  - Shi Yin
PY  - 2026
DA  - 2026/10/08
JO  - Molecules
DO  - 10.3390/molecules31193575
UR  - https://www.mdpi.com/1420-3049/31/19/3575
AB  - Salidroside is a bioactive compound extracted from the traditional Chinese medicinal plant Rhodiola rosea that exerts differential regulatory effects on cell viability depending on cell type and physiological state. Sertoli cells are important testicular somatic cells that play multiple roles in nourishing, protecting, and supporting spermatogenic cells. Currently, the regulatory effects and underlying mechanisms of salidroside on Sertoli cells remain unclear. This study investigated the effects of different concentrations of salidroside on the viability and regulatory mechanisms of TM4 cells (mouse Sertoli cell line). The results showed that within the range of 25–600 μM, cell viability decreased with increasing salidroside concentration. Treatment with 600 μM salidroside inhibited proliferation, promoted apoptosis, and suppressed the expression of key genes related to Sertoli cell function. Transcriptome sequencing revealed that several glycolysis-related genes, including Ldha, Pfkl, Eno3, and Eno1b, were significantly downregulated in salidroside-treated cells, accompanied by marked reductions in key glycolytic metabolites, including fructose-1,6-diphosphate (FDP), pyruvate, lactic acid, and ATP. Notably, overexpression of lactate dehydrogenase A (Ldha) rescued cell viability and proliferation, suppressed apoptosis, elevated both intracellular and extracellular lactate and ATP levels, and partially restored functional gene expression in 600 μM salidroside-treated cells. Overall, this study provides hitherto undocumented evidence of the regulatory effects and mechanisms of salidroside on TM4 cells, identifying the Ldha–glycolytic axis as an in vitro cellular target of high-dose salidroside in Sertoli cells, which may inform future in vivo reproductive safety profiling pending pharmacokinetic validation.
SN  - 1420-3049
ER  -